Recombinant Human KLK13/Kallik

Recombinant Human KLK13/Kallikrein 13  (C362)

 

产品说明(Description)

Recombinant Human Kallikrein 13 is produced by our Mammalian expression system and the target gene encoding Gly17-Ile262 is expressed with a 6His tag at the C-terminus. 

Accession #: Q9UKR3

Known as: Kallikrein-13; Kallikrein-Like Protein 4; KLK-L4; KLK13; KLKL4

 

制剂（Formulation）

Supplied as a 0.2 μm filtered solution of 20mM MES, 150mM NaCl, 10% Glycerol, pH 5.5.

 

质量控制（Quality Control） 

 

Purity:            Greater than 95% as determined by reducing SDS-PAGE.    

Endotoxin:    Less than 0.1 ng/ug (1 EU/ug) as determined by LAL test.

 

 

运输(Shipping)

The product is shipped on dry ice/polar packs. 
Upon receipt, store it immediately at the temperature listed below.

 

保存(Storage)

Store at ≤-70°C, stable for 6 months after receipt.
Store at ≤-70°C, stable for 3 months under sterile conditions after opening. 
Please minimize freeze-thaw cycles.     

 

背景（Background）

Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many Kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen Kallikrein subfamily members located in a cluster on chromosome 19. Its encoded protein is secreted and may play a role in suppression of tumorigenesis in breast and prostate cancers. Alternate splicing of this gene results in multiple transcript variants encoding the same protein.

 

电泳(SDS-PAGE)

 

 

 

FOR RESEARCH USE ONLY